Report of Foreign Issuer (6-k)
April 21 2015 - 6:07AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
Pursuant to Rule 13a-16 or 15d-16 of
The Securities Exchange Act of 1934
For the month of April 2015
PACIFIC THERAPEUTICS LTD.
(Translation of registrant’s name into English)
409 Granville Street, Suite #1500
Vancouver, BC, V6C-1T2 Canada
Tel: 604-738-1049
Fax: 604-738-1094
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form 40-F o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes o No x
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):
Resignation of Auditor
The Company has accepted the resignation of James Stafford Inc. Chartered Accountants ("Stafford") as auditor of the Company and are currently in discussions with another firm to be its successor and will announce the appointment of the new auditor when finalized. There were no reservations in Stafford’s reports on any of the financial statements of the Company commencing at the beginning of the most recently completed fiscal years and ending on 31, December 2013. There were also no reportable events between the Company and Stafford.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: April 17, 2015
| |
PACIFIC THERAPEUTICS LTD |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
By:
|
/s/ Douglas H. Unwin
|
|
| |
Name:
|
Douglas H. Unwin
|
|
| |
Title:
|
CEO
|
|
| |
|
|
|
3
EXHIBIT 99.1
PACIFIC THERAPEUTICS LTD. ANNOUNCES CHANGE OF AUDITORS
VANCOUVER, BC, Canada – April 16, 2015 – Pacific Therapeutics Ltd. (CNSX: PT) (OTC:PCFTF) (Frankfurt: 1P3) (the “Company”) announces that effective April 16, 2015 the Company is in discussions to replace its Auditor.
The Company has accepted the resignation of James Stafford Inc. Chartered Accountants ("Stafford") as auditor of the Company and are currently in discussions with another firm to be its successor and will announce the appointment of the new auditor when finalized. There were no reservations in Stafford’s reports on any of the financial statements of the Company commencing at the beginning of the most recently completed fiscal years and ending on 31, December 2013. There were also no reportable events between the Company and Stafford.
In accordance with NI 51-102, a notice of change of auditor, together with the required letters from the auditor have been filed on SEDAR
For further information visit our website at www.pacifictherapeutics.com or email us at doug.unwin@pacifictherapeutics.com
Douglas H. Unwin, CEO & President
(604) 738-1049
doug.unwin@pacifictherapeutics.com
FORWARD LOOKING STATEMENTS
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.
409 Granville Street Suite 1023, Vancouver, BC V6C 1T2
Ph: (604) 738-1049 Fax: (604) 738-1094
Polar Cap Global Financi... (PK) (USOTC:PCFTF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Polar Cap Global Financi... (PK) (USOTC:PCFTF)
Historical Stock Chart
From Apr 2023 to Apr 2024
